000			01919 a2200565 4500
005			20250517171233.0
264		0	_c20180531
008			201805s 0 0 eng d
022			_a1095-9157
024	7		_a10.1016/j.jaut.2017.08.004 _2doi
040			_aNLM _beng _cNLM
100	1		_aSun, Haoping
245	0	0	_aRecombinant human IgG1 based Fc multimers, with limited FcR binding capacity, can effectively inhibit complement-mediated disease. _h[electronic resource]
260			_bJournal of autoimmunity _cNov 2017
300			_a97-108 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAnimals
650	0	4	_aCells, Cultured
650	0	4	_aComplement C1q _ximmunology
650	0	4	_aComplement C3 _xmetabolism
650	0	4	_aComplement System Proteins _ximmunology
650	0	4	_aCytotoxicity, Immunologic
650	0	4	_aDisease Models, Animal
650	0	4	_aErythrocytes _xphysiology
650	0	4	_aGlomerulonephritis, Membranous
650	0	4	_aHemolysis
650	0	4	_aHumans
650	0	4	_aImmune System Diseases _ximmunology
650	0	4	_aImmunoglobulin Fc Fragments _xgenetics
650	0	4	_aImmunoglobulin G _xgenetics
650	0	4	_aMolecular Targeted Therapy
650	0	4	_aProtein Binding
650	0	4	_aProtein Multimerization
650	0	4	_aReceptors, Fc _xmetabolism
650	0	4	_aThy-1 Antigens _ximmunology
650	0	4	_aTransgenes _xgenetics
700	1		_aOlsen, Henrik S
700	1		_aMérigeon, Emmanuel Y
700	1		_aSo, Edward
700	1		_aBurch, Erin
700	1		_aKinsey, Susan
700	1		_aPapadimitriou, John C
700	1		_aDrachenberg, Cinthia B
700	1		_aBentzen, Søren M
700	1		_aBlock, David S
700	1		_aStrome, Scott E
700	1		_aZhang, Xiaoyu
773	0		_tJournal of autoimmunity _gvol. 84 _gp. 97-108
856	4	0	_uhttps://doi.org/10.1016/j.jaut.2017.08.004 _zAvailable from publisher's website
999			_c27487702 _d27487702